77 related articles for article (PubMed ID: 2293545)
1. On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells.
Liliemark J; Pettersson B; Engberg B; Lafolie P; Masquelier M; Peterson C
Cancer Res; 1990 Jan; 50(1):108-12. PubMed ID: 2293545
[TBL] [Abstract][Full Text] [Related]
2. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro.
Liliemark J; Pettersson B; Peterson C
Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210
[TBL] [Abstract][Full Text] [Related]
3. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
[TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.
Zimm S; Johnson GE; Chabner BA; Poplack DG
Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397
[TBL] [Abstract][Full Text] [Related]
5. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.
Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC
Cancer Res; 1995 Oct; 55(19):4352-60. PubMed ID: 7671247
[TBL] [Abstract][Full Text] [Related]
6. Conversion of 6-mercaptopurine to 6-thioguanylic acid in L-1210 cells and human leukemia cells.
Uchida M; Nakamura T; Uchino H
Jpn J Cancer Res; 1985 Feb; 76(2):124-30. PubMed ID: 2858424
[TBL] [Abstract][Full Text] [Related]
7. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of intracellular metabolites of [35S]-6-mercaptopurine in L5178Y cells grown in time-course incubates.
Breter HJ; Zahn RK
Cancer Res; 1979 Sep; 39(9):3744-8. PubMed ID: 476698
[TBL] [Abstract][Full Text] [Related]
9. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
10. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
Zimm S; Johnson GE; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
[TBL] [Abstract][Full Text] [Related]
11. Comparative kinetics of poly(6-thioinosinic acid) and 6-mercaptopurine treated L1210 cells.
Tomasovic SP; Higashikubo R; Cohen AM; Broom AD
Cytometry; 1982 Jul; 3(1):48-54. PubMed ID: 6889485
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.
Innocenti F; Danesi R; Bocci G; Fogli S; Di Paolo A; Del Tacca M
Cancer Chemother Pharmacol; 1999; 43(2):133-40. PubMed ID: 9923818
[TBL] [Abstract][Full Text] [Related]
13. The role of xanthine oxidase in thiopurine metabolism: a case report.
Wong DR; Derijks LJ; den Dulk MO; Gemmeke EH; Hooymans PM
Ther Drug Monit; 2007 Dec; 29(6):845-8. PubMed ID: 18043486
[TBL] [Abstract][Full Text] [Related]
14. Msh2 deficiency attenuates but does not abolish thiopurine hematopoietic toxicity in msh2-/- mice.
Krynetskaia NF; Brenner TL; Krynetski EY; Du W; Panetta JC; Ching-Hon P; Evans WE
Mol Pharmacol; 2003 Aug; 64(2):456-65. PubMed ID: 12869651
[TBL] [Abstract][Full Text] [Related]
15. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
[TBL] [Abstract][Full Text] [Related]
16. Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.
Brouwer C; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ; Bökkerink JP; Hoogerbrugge PM; van Wering ER; Veerman AJ; De Abreu RA
Clin Chim Acta; 2005 Nov; 361(1-2):95-103. PubMed ID: 15990089
[TBL] [Abstract][Full Text] [Related]
17. Human lymphocyte thiopurine methyltransferase pharmacogenetics: effect of phenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation.
Van Loon JA; Weinshilboum RM
J Pharmacol Exp Ther; 1987 Jul; 242(1):21-6. PubMed ID: 3612526
[TBL] [Abstract][Full Text] [Related]
18. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo.
Giverhaug T; Fuskevaag OM; Aarbakke J
Cancer Chemother Pharmacol; 1997; 40(4):367-70. PubMed ID: 9225958
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
